Author: Web Team

Experiment measures millions of quantum trajectories to predict ‘most likely’ route As a quantum state collapses from a quantum superposition to a classical state or a different superposition, it will follow a path known as a quantum trajectory. For each start and end state there

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. Health Care Originals (Rochester, NY) is negotiating a license for a

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. Ovitz Corporation (West Henrietta, NY) intends to develop and commercialize a

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. Raland Therapeutics, Inc. (Fairport, NY) has licensed three technologies from the

Recently, 113 semi-finalists were announced in the 2014 43 North $1 million business plan competition. Ten of those semi-finalists are from the Rochester area. Four of those are connected to University of Rochester technologies. SmartDialysis (Rochester, NY) is trying to create a portable hemodialysis device

On 15 July 2014, nearly 7,000 applicants from 96 countries were winnowed down to 113 semi-finalists in the $1 Million 43 North Business Plan Competition. It is very exciting to see that ten of the semi-finalists are from the Greater Rochester Area! They are: Artwork

The UR Ventures web site underwent a minor update last week. We have simplified navigation within the site, hopefully making the things you’re looking for a little easier to find. As always, we welcome your feedback. Send comments and suggestions to the e-mail link, below.

The Winter/Spring 2014 issue of Endeavor (a publication of the Office of Advancement Communications) contains a nice write-up of the TDF . . . what it is and why it’s so very important to our research enterprise. View the article online here. While you’re there,

Eighty faculty and students from the University of Rochester and Cornell converged in Ithaca on Tuesday, 6 May 2014 for the Upstate New York Health Sciences Symposium and Technology Showcase. Attendees heard presentations from Cancer Biology and Neurobiology researchers and later mingled among more than

David Williams, one of the world’s leading experts on human vision, has been named a member of the National Academy of Sciences in recognition of his distinguished and continuing achievements in original research. The honor is one of the highest given to a scientist in

BIOWORLD TODAY, 21 April 2014 By Marie Powers, Staff Writer In Greek mythology, Telephus was a son of Heracles who received a wound in battle that would not heal until he returned to the Greek warrior, Achilles, who had inflicted the injury. He was healed

Today, University of Rochester President Joel Seligman announced two extraordinary gifts from The Wegman Family Charitable Foundation (WFCF): a $10 million lead gift to the University’s Institute for Data Science and a $7 million gift to support Golisano Children’s Hospital. Together with previous gifts to

Two UR studies have been taped by Science magazine as among last year’s most important scientific breakthroughs. Naked mole rats – animals that may hold the key to new cancer treatments – were named Vertebrate of the Year, while research that shows that the brain

A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson’s disease.  These findings, which were made using an animal model of the disease, demonstrate that a

Palo Alto, CA – March 6, 2014 — iCardiac Technologies, Inc., a leading global provider of cardiac safety assessment services, today announced a partnership transaction with Norwest Venture Partners (NVP), a global, multi-stage investment firm with $3.7 billion in capital under management. iCardiac will leverage the